Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Atovaquone/proguanil-induced autoimmune-like hepatitis.

Hepatology communications

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Bertoli R, Mazzucchelli L, Nofziger C, Paulmichl M, Vergani D.
PMID: 29404460
Hepatol Commun. 2017 May 08;1(4):293-298. doi: 10.1002/hep4.1039. eCollection 2017 Jun.

We report a novel association between the commonly used antimalarial medication atovaquone/proguanil and drug-induced autoimmune-like hepatitis. The patient developed severe liver disease fulfilling biochemical, immunologic, and histologic criteria for the diagnosis of autoimmune hepatitis after the inadvertent rechallenge with...

Cite
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Bertoli R, et al. Atovaquone/proguanil-induced autoimmune-like hepatitis. Hepatol Commun. 2017;1(4):293-298doi: 10.1002/hep4.1039.
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Bertoli, R., Mazzucchelli, L., Nofziger, C., Paulmichl, M., & Vergani, D. (2017). Atovaquone/proguanil-induced autoimmune-like hepatitis. Hepatology communications, 1(4), 293-298. https://doi.org/10.1002/hep4.1039
Terziroli Beretta-Piccoli, Benedetta, et al. "Atovaquone/proguanil-induced autoimmune-like hepatitis." Hepatology communications vol. 1,4 (2017): 293-298. doi: https://doi.org/10.1002/hep4.1039
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Bertoli R, Mazzucchelli L, Nofziger C, Paulmichl M, Vergani D. Atovaquone/proguanil-induced autoimmune-like hepatitis. Hepatol Commun. 2017 May 08;1(4):293-298. doi: 10.1002/hep4.1039. eCollection 2017 Jun. PMID: 29404460; PMCID: PMC5721398.
Copy Download .nbib Format: NLM
A reasoned approach to the treatment of autoimmune hepatitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G.
PMID: 34162505
Dig Liver Dis. 2021 Nov;53(11):1381-1393. doi: 10.1016/j.dld.2021.05.033. Epub 2021 Jun 23.

Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease affecting all ages, characterised by elevated transaminase and immunoglobulin G levels, positive autoantibodies, interface hepatitis on histology and good response to immunosuppressive treatment. If untreated, it has a poor prognosis....

Cite
Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. A reasoned approach to the treatment of autoimmune hepatitis. Dig Liver Dis. 2021;53(11):1381-1393doi: 10.1016/j.dld.2021.05.033.
Vergani, D., Terziroli Beretta-Piccoli, B., & Mieli-Vergani, G. (2021). A reasoned approach to the treatment of autoimmune hepatitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(11), 1381-1393. https://doi.org/10.1016/j.dld.2021.05.033
Vergani, Diego, et al. "A reasoned approach to the treatment of autoimmune hepatitis." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,11 (2021): 1381-1393. doi: https://doi.org/10.1016/j.dld.2021.05.033
Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. A reasoned approach to the treatment of autoimmune hepatitis. Dig Liver Dis. 2021 Nov;53(11):1381-1393. doi: 10.1016/j.dld.2021.05.033. Epub 2021 Jun 23. PMID: 34162505.
Copy Download .nbib Format: NLM
A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome.

Journal of translational autoimmunity

Terziroli Beretta-Piccoli B, Mazzucchelli L, Taiana C, Mossi G, Usai C, Vergani D, Mieli-Vergani G.
PMID: 32743518
J Transl Autoimmun. 2019 Dec 17;3:100033. doi: 10.1016/j.jtauto.2019.100033. eCollection 2020.

Overlap between autoimmune hepatitis (AIH) and either primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC) is not rare and has extensively been reported. We herein report the first well documented case of triple overlap. A 68-year-old male patient...

Cite
Terziroli Beretta-Piccoli B, Mazzucchelli L, Taiana C, et al. A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome. J Transl Autoimmun. 2019;3:100033doi: 10.1016/j.jtauto.2019.100033.
Terziroli Beretta-Piccoli, B., Mazzucchelli, L., Taiana, C., Mossi, G., Usai, C., Vergani, D., & Mieli-Vergani, G. (2020). A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome. Journal of translational autoimmunity, 3100033. https://doi.org/10.1016/j.jtauto.2019.100033
Terziroli Beretta-Piccoli, Benedetta, et al. "A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome." Journal of translational autoimmunity vol. 3 (2020): 100033. doi: https://doi.org/10.1016/j.jtauto.2019.100033
Terziroli Beretta-Piccoli B, Mazzucchelli L, Taiana C, Mossi G, Usai C, Vergani D, Mieli-Vergani G. A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome. J Transl Autoimmun. 2019 Dec 17;3:100033. doi: 10.1016/j.jtauto.2019.100033. eCollection 2020. PMID: 32743518; PMCID: PMC7388380.
Copy Download .nbib Format: NLM
Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice.

Clinical reviews in allergy & immunology

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D.
PMID: 34491531
Clin Rev Allergy Immunol. 2021 Sep 07; doi: 10.1007/s12016-021-08888-9. Epub 2021 Sep 07.

Circulating autoantibodies are a key diagnostic tool in autoimmune hepatitis (AIH), being positive in 95% of the cases if tested according to dedicated guidelines issued by the International Autoimmune Hepatitis Group. They also allow the distinction between type 1...

Cite
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clin Rev Allergy Immunol. 2021;doi: 10.1007/s12016-021-08888-9.
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2021). Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clinical reviews in allergy & immunology, . https://doi.org/10.1007/s12016-021-08888-9
Terziroli Beretta-Piccoli, Benedetta, et al. "Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice." Clinical reviews in allergy & immunology vol. (2021). doi: https://doi.org/10.1007/s12016-021-08888-9
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clin Rev Allergy Immunol. 2021 Sep 07; doi: 10.1007/s12016-021-08888-9. Epub 2021 Sep 07. PMID: 34491531.
Copy Download .nbib Format: NLM
Autoimmmune hepatitis.

Cellular & molecular immunology

Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D.
PMID: 34580437
Cell Mol Immunol. 2021 Sep 27; doi: 10.1038/s41423-021-00768-8. Epub 2021 Sep 27.

Autoimmune hepatitis (AIH) is a T-cell mediated, inflammatory liver disease affecting all ages and characterized by female preponderance, elevated serum transaminase and immunoglobulin G levels, positive circulating autoantibodies, and presence of interface hepatitis at liver histology. AIH type 1,...

Cite
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol. 2021;doi: 10.1038/s41423-021-00768-8.
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2021). Autoimmmune hepatitis. Cellular & molecular immunology, . https://doi.org/10.1038/s41423-021-00768-8
Terziroli Beretta-Piccoli, Benedetta, et al. "Autoimmmune hepatitis." Cellular & molecular immunology vol. (2021). doi: https://doi.org/10.1038/s41423-021-00768-8
Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol. 2021 Sep 27; doi: 10.1038/s41423-021-00768-8. Epub 2021 Sep 27. PMID: 34580437; PMCID: PMC8475398.
Copy Download .nbib Format: NLM
ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Avena A, Puggelli S, Morris M, Cerny A, Andrade AR, Pareti E, Bihl F, Cassatella D, Moix I, Merlo E, Rougemont AL, Majno-Hurst P, Vergani D, Mieli-Vergani G, Terziroli Beretta-Piccoli B.
PMID: 33390354
Dig Liver Dis. 2021 Mar;53(3):329-344. doi: 10.1016/j.dld.2020.12.003. Epub 2020 Dec 31.

BACKGROUND: Heterozygous ABCB4 variants are not routinely tested in adults with cholestasis because of their supposed rarity and high costs.METHODS: Nineteen adult patients presenting with unexplained cholestasis, and/or recurrent gallstones were included; genotyping was not done in five due...

Cite
Avena A, Puggelli S, Morris M, et al. ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed. Dig Liver Dis. 2020;53(3):329-344doi: 10.1016/j.dld.2020.12.003.
Avena, A., Puggelli, S., Morris, M., Cerny, A., Andrade, A. R., Pareti, E., Bihl, F., Cassatella, D., Moix, I., Merlo, E., Rougemont, A. L., Majno-Hurst, P., Vergani, D., Mieli-Vergani, G., & Terziroli Beretta-Piccoli, B. (2021). ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(3), 329-344. https://doi.org/10.1016/j.dld.2020.12.003
Avena, Antonella, et al. "ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,3 (2021): 329-344. doi: https://doi.org/10.1016/j.dld.2020.12.003
Avena A, Puggelli S, Morris M, Cerny A, Andrade AR, Pareti E, Bihl F, Cassatella D, Moix I, Merlo E, Rougemont AL, Majno-Hurst P, Vergani D, Mieli-Vergani G, Terziroli Beretta-Piccoli B. ABCB4 variants in adult patients with cholestatic disease are frequent and underdiagnosed. Dig Liver Dis. 2021 Mar;53(3):329-344. doi: 10.1016/j.dld.2020.12.003. Epub 2020 Dec 31. PMID: 33390354.
Copy Download .nbib Format: NLM
A reasoned approach to the treatment of autoimmune hepatitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G.
PMID: 34162505
Dig Liver Dis. 2021 Nov;53(11):1381-1393. doi: 10.1016/j.dld.2021.05.033. Epub 2021 Jun 23.

Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease affecting all ages, characterised by elevated transaminase and immunoglobulin G levels, positive autoantibodies, interface hepatitis on histology and good response to immunosuppressive treatment. If untreated, it has a poor prognosis....

Cite
Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. A reasoned approach to the treatment of autoimmune hepatitis. Dig Liver Dis. 2021;53(11):1381-1393doi: 10.1016/j.dld.2021.05.033.
Vergani, D., Terziroli Beretta-Piccoli, B., & Mieli-Vergani, G. (2021). A reasoned approach to the treatment of autoimmune hepatitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(11), 1381-1393. https://doi.org/10.1016/j.dld.2021.05.033
Vergani, Diego, et al. "A reasoned approach to the treatment of autoimmune hepatitis." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,11 (2021): 1381-1393. doi: https://doi.org/10.1016/j.dld.2021.05.033
Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. A reasoned approach to the treatment of autoimmune hepatitis. Dig Liver Dis. 2021 Nov;53(11):1381-1393. doi: 10.1016/j.dld.2021.05.033. Epub 2021 Jun 23. PMID: 34162505.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries